Jefferies Group’s Pacira BioSciences PCRX Stock Holding History

Jefferies Group’s Portfolio PCRX Stock Details PCRX Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.59M	Buy	29,954 +22,454	+299%	+$1.19M	0.01%	390
2022 Q2	$437K	Buy	+7,500	New	+$437K	﹤0.01%	636
2021 Q4	–	Sell	-28,755	Closed	-$1.61M	–	1234
2021 Q3	$1.61M	Buy	+28,755	New	+$1.61M	0.01%	451
2021 Q2	–	Sell	-11,000	Closed	-$771K	–	1278
2021 Q1	$771K	Sell	11,000 -8,586	-44%	-$602K	0.01%	612
2020 Q4	$1.17M	Buy	19,586 +6,550	+50%	+$392K	0.01%	498
2020 Q3	$784K	Buy	13,036 +6,036	+86%	+$363K	0.01%	508
2020 Q2	$367	Sell	7,000 -188,393	-96%	-$9.88K	﹤0.01%	572
2020 Q1	$6.55M	Buy	+195,393	New	+$6.55M	0.07%	107
2019 Q4	–	Sell	-35	Closed	-$1K	–	1845
2019 Q3	$1K	Sell	35 -37,500	-100%	-$1.07M	﹤0.01%	1652
2019 Q2	$1.63M	Buy	37,535 +14,054	+60%	+$611K	0.01%	516
2019 Q1	$894K	Buy	23,481 +8,044	+52%	+$306K	0.01%	751
2018 Q4	$664K	Sell	15,437 -5,919	-28%	-$255K	0.01%	778
2018 Q3	$1.05M	Buy	21,356 +17,960	+529%	+$883K	0.01%	710
2018 Q2	$109K	Buy	+3,396	New	+$109K	﹤0.01%	1415
2018 Q1	–	Sell	-10,303	Closed	-$470K	–	1772
2017 Q4	$470K	Sell	10,303 -2,939	-22%	-$134K	﹤0.01%	1091
2017 Q3	$497K	Sell	13,242 -11,052	-45%	-$415K	﹤0.01%	982
2017 Q2	$1.16M	Sell	24,294 -7,787	-24%	-$371K	0.01%	665
2017 Q1	$1.46M	Buy	+32,081	New	+$1.46M	0.01%	538
2016 Q4	–	Sell	-10,721	Closed	-$367K	–	1444
2016 Q3	$367K	Buy	10,721 +714	+7%	+$24.4K	﹤0.01%	906
2016 Q2	$338K	Buy	+10,007	New	+$338K	﹤0.01%	828
2016 Q1	–	Sell	-5,000	Closed	-$384K	–	1475
2015 Q4	$384K	Buy	5,000 +1,800	+56%	+$138K	﹤0.01%	850
2015 Q3	$132K	Buy	3,200 +2,600	+433%	+$107K	﹤0.01%	1130
2015 Q2	$42K	Buy	+600	New	+$42K	﹤0.01%	1606
2015 Q1	–	Hold	0	–	–	–	1492
2014 Q3	–	Sell	-10,500	Closed	-$965K	–	1575
2014 Q2	$965K	Sell	10,500 -66,783	-86%	-$6.14M	0.01%	469
2014 Q1	$5.41M	Buy	+77,283	New	+$5.41M	0.05%	87
2013 Q4	–	Sell	-7,708	Closed	-$371K	–	1411
2013 Q3	$371K	Sell	7,708 -16,827	-69%	-$810K	﹤0.01%	733
2013 Q2	$712K	Buy	+24,535	New	+$712K	0.01%	436